Bronstein Ben 4
4 · Aldeyra Therapeutics, Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Bronstein Ben
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-10+62,728→ 62,728 totalExercise: $2.69Exp: 2035-06-09→ Common Stock (62,728 underlying) - Award
Stock Option (Right to Buy)
2025-06-10+3,619→ 3,619 totalExercise: $2.69Exp: 2035-06-09→ Common Stock (3,619 underlying) - Award
Stock Option (Right to Buy)
2024-06-10+3,860→ 3,860 totalExercise: $2.69Exp: 2035-06-09→ Common Stock (3,860 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.